MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$4.13−0.03 (-0.72%)
Close on Nov 13, 2026Market cap $1.33BP/E –Yield –
MannKind gross margin
Gross margin is gross profit as a percentage of revenue.
MannKind's gross margin for the twelve months ending Sep 30, 2026 was 88.6%. For fiscal 2025 it was 92.3%, against 93.9% the year before. The highest annual figure on record is 93.9% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 92.3% | −1.6 |
| FY2024 | Dec 31, 2024 | 93.9% | +4.4 |
| FY2023 | Dec 31, 2023 | 89.5% | +5.6 |
| FY2022 | Dec 31, 2022 | 84.0% | +6.3 |
| FY2021 | Dec 31, 2021 | 77.7% | +0.8 |
| FY2020 | Dec 31, 2020 | 76.8% | +8.7 |
| FY2019 | Dec 31, 2019 | 68.1% | +37.8 |
| FY2018 | Dec 31, 2018 | 30.4% | +77.1 |
| FY2017 | Dec 31, 2017 | -46.7% | −136.9 |
| FY2016 | Dec 31, 2016 | 90.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 89.0% | −5.5 |
| Q2 FY2026 | Jun 30, 2026 | 86.8% | −7.2 |
| Q1 FY2026 | Mar 31, 2026 | 91.7% | −3.5 |
| Q4 FY2025 | Dec 31, 2025 | 87.6% | −6.2 |
| Q3 FY2025 | Sep 30, 2025 | 94.5% | −0.9 |
| Q2 FY2025 | Jun 30, 2025 | 94.0% | +1.7 |
| Q1 FY2025 | Mar 31, 2025 | 95.2% | +1.0 |
| Q4 FY2024 | Dec 31, 2024 | 93.7% | +4.2 |
| Q3 FY2024 | Sep 30, 2024 | 95.4% | +3.2 |
| Q2 FY2024 | Jun 30, 2024 | 92.3% | +3.0 |
| Q1 FY2024 | Mar 31, 2024 | 94.2% | +7.8 |
| Q4 FY2023 | Dec 31, 2023 | 89.5% | +0.9 |
| Q3 FY2023 | Sep 30, 2023 | 92.2% | +7.5 |
| Q2 FY2023 | Jun 30, 2023 | 89.3% | +13.7 |
| Q1 FY2023 | Mar 31, 2023 | 86.4% | +5.4 |
| Q4 FY2022 | Dec 31, 2022 | 88.7% | +23.0 |
| Q3 FY2022 | Sep 30, 2022 | 84.7% | +1.9 |
| Q2 FY2022 | Jun 30, 2022 | 75.6% | −5.5 |
| Q1 FY2022 | Mar 31, 2022 | 81.0% | +5.7 |
| Q4 FY2021 | Dec 31, 2021 | 65.7% | −14.5 |
| Q3 FY2021 | Sep 30, 2021 | 82.8% | +6.2 |
| Q2 FY2021 | Jun 30, 2021 | 81.1% | +5.4 |
| Q1 FY2021 | Mar 31, 2021 | 75.3% | +0.9 |
| Q4 FY2020 | Dec 31, 2020 | 80.2% | +9.2 |
| Q3 FY2020 | Sep 30, 2020 | 76.6% | +25.2 |
| Q2 FY2020 | Jun 30, 2020 | 75.7% | +4.5 |
| Q1 FY2020 | Mar 31, 2020 | 74.4% | −2.6 |
| Q4 FY2019 | Dec 31, 2019 | 71.0% | +2.1 |
| Q3 FY2019 | Sep 30, 2019 | 51.4% | +70.0 |
| Q2 FY2019 | Jun 30, 2019 | 71.2% | +102.0 |
| Q1 FY2019 | Mar 31, 2019 | 77.0% | +92.6 |
| Q4 FY2018 | Dec 31, 2018 | 68.9% | +79.7 |
| Q3 FY2018 | Sep 30, 2018 | -18.7% | +105.3 |
| Q2 FY2018 | Jun 30, 2018 | -30.9% | +104.3 |
| Q1 FY2018 | Mar 31, 2018 | -15.7% | −31.0 |
| Q4 FY2017 | Dec 31, 2017 | -10.8% | −76.8 |
| Q3 FY2017 | Sep 30, 2017 | -123.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -135.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 15.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 66.1% | – |
See a number that looks wrong?